NCT02036931

Brief Summary

This is a prospective observational multi-center non-controlled study. The primary purpose of this study is to evaluate the clinical and radiographic performance of the G7 Acetabular Cup System.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2013

Longer than P75 for all trials

Geographic Reach
6 countries

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 14, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 15, 2014

Completed
10.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
8 months until next milestone

Results Posted

Study results publicly available

December 19, 2025

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

11.8 years

First QC Date

January 14, 2014

Results QC Date

October 28, 2025

Last Update Submit

December 5, 2025

Conditions

Keywords

JointOsteoarthritisAvascular Necrosis

Outcome Measures

Primary Outcomes (1)

  • Harris Hip Score

    The Harris Hip Scale (HHS) is an outcome measure that includes a series of questions answered by the patient and physical examinations recorded by a qualified health care professional. The HHS covers four domains: pain (one item, 0-44 points), function and functional activities (seven items, 0-47 points), absence of deformity (one item, 0-4 points) and range of motion (one item, o-5 points). To obtain a final score, the points are summed. The outcome score can be categorized as Excellent:90 - 100; Good: 80 - 90; Fair: 70 - 80; Poor: \< 70.

    Pre-operative,1, 2, and 5 years postoperatively

Secondary Outcomes (4)

  • Oxford Hip Score

    Pre-op, 1, 2, and 5 years postoperatively

  • Survivorship

    7 and 10 Year post-operative

  • Survivorship

    10 Year post-operative

  • Radiographic Evaluation

    Immediate post-op, 3 months, 1, 2, and 5 years

Study Arms (3)

Metal on Polyethylene articulation

G7 cup with Metal on Polyethylene articulation (MOP)

Device: Metal on Polyethylene articulation

Ceramic on Polyethylene articulation

G7 cup with Ceramic on Polyethylene articulation (COP)

Device: Ceramic on Polyethylene articulation

Ceramic on Ceramic articulation

G7 cup with Ceramic on Ceramic articulation (COC)

Device: Ceramic on Ceramic articulation

Interventions

G7 Acetabular Cup System with Metal head on Polyethylene liner articulation (MOP)

Also known as: MOP
Metal on Polyethylene articulation

G7 Acetabular Cup System with Ceramic head on Polyethylene liner articulation (COP)

Also known as: COP
Ceramic on Polyethylene articulation

G7 Acetabular Cup System with Ceramic head on Ceramic linear articulation (COC) - Outside the United States ONLY

Also known as: COC
Ceramic on Ceramic articulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary care clinic

You may qualify if:

  • Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis
  • Rheumatoid arthritis
  • Correction of functional deformity
  • Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
  • Revision procedures where other treatment or devices have failed
  • years of age or older
  • Subjects willing to return for follow-up evaluations

You may not qualify if:

  • Infection, sepsis and osteomyelitis
  • Subjects unable to cooperate with and complete the study
  • Neurological conditions affecting movement
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

University Orthopedic Specialists

Tucson, Arizona, 85718, United States

Location

Clermont-Ferrand Hospital

Clermont-Ferrand, France

Location

University of Würzburg, Orthopedic

Würzburg, Germany

Location

Midwestern Regional Orthopaedic Hospital

Limerick, Ireland

Location

Reinier de Graaf Groep

Delft, Netherlands

Location

Hospital El Bierzo

Ponferrada, Spain

Location

MeSH Terms

Conditions

Arthritis, RheumatoidOsteoarthritisOsteonecrosis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Oliver Marti
Organization
Zimmer Biomet

Study Officials

  • Emilie Rohmer

    Zimmer Biomet

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 14, 2014

First Posted

January 15, 2014

Study Start

March 1, 2013

Primary Completion

December 1, 2024

Study Completion

May 1, 2025

Last Updated

December 19, 2025

Results First Posted

December 19, 2025

Record last verified: 2025-12

Locations